Futoshi Uno

1.7k total citations
46 papers, 1.4k citations indexed

About

Futoshi Uno is a scholar working on Genetics, Molecular Biology and Biotechnology. According to data from OpenAlex, Futoshi Uno has authored 46 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Genetics, 17 papers in Molecular Biology and 16 papers in Biotechnology. Recurrent topics in Futoshi Uno's work include Virus-based gene therapy research (20 papers), Cancer Research and Treatments (16 papers) and RNA Interference and Gene Delivery (8 papers). Futoshi Uno is often cited by papers focused on Virus-based gene therapy research (20 papers), Cancer Research and Treatments (16 papers) and RNA Interference and Gene Delivery (8 papers). Futoshi Uno collaborates with scholars based in Japan, United States and Australia. Futoshi Uno's co-authors include Toshiyoshi Fujiwara, Shunsuke Kagawa, Noriaki Tanaka, Yuuri Hashimoto, Yasuo Urata, Yuichi Watanabe, Hiroshi Tazawa, Shinji Kuroda, Jack A. Roth and Shuya Yano and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and The Journal of Immunology.

In The Last Decade

Futoshi Uno

41 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Futoshi Uno Japan	20	784	579	549	409	215	46	1.4k
Dawn E. Post United States	14	727 0.9×	348 0.6×	499 0.9×	155 0.4×	62 0.3×	18	1.2k
Jack A. Roth United States	17	1.1k 1.4×	906 1.6×	725 1.3×	457 1.1×	39 0.2×	28	1.9k
Dongping Wei China	21	870 1.1×	472 0.8×	117 0.2×	164 0.4×	113 0.5×	33	1.2k
Gail Eckhardt United States	12	850 1.1×	900 1.6×	319 0.6×	170 0.4×	42 0.2×	20	1.6k
Shu Fen Wen United States	15	857 1.1×	626 1.1×	466 0.8×	258 0.6×	46 0.2×	18	1.3k
Habib Fakhrai United States	19	990 1.3×	1.1k 1.9×	250 0.5×	213 0.5×	75 0.3×	35	2.1k
Jean‐Gabriel Judde France	19	581 0.7×	946 1.6×	115 0.2×	132 0.3×	74 0.3×	42	1.5k
Trevor G. Shepherd Canada	26	1.1k 1.4×	644 1.1×	173 0.3×	53 0.1×	189 0.9×	64	1.8k
Adam D. Steg United States	20	1.2k 1.5×	852 1.5×	221 0.4×	55 0.1×	114 0.5×	44	1.8k
Avi Shvarts Netherlands	11	717 0.9×	532 0.9×	183 0.3×	151 0.4×	51 0.2×	18	1.1k

Countries citing papers authored by Futoshi Uno

Since Specialization

Citations

This map shows the geographic impact of Futoshi Uno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Futoshi Uno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Futoshi Uno more than expected).

Fields of papers citing papers by Futoshi Uno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Futoshi Uno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Futoshi Uno. The network helps show where Futoshi Uno may publish in the future.

Co-authorship network of co-authors of Futoshi Uno

This figure shows the co-authorship network connecting the top 25 collaborators of Futoshi Uno. A scholar is included among the top collaborators of Futoshi Uno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Futoshi Uno. Futoshi Uno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tanioka, Hiroaki, Takeshi Nagasaka, Futoshi Uno, et al.. (2019). The relationship between peripheral neuropathy and efficacy in second-line chemotherapy for unresectable advanced gastric cancer: a prospective observational multicenter study protocol (IVY). BMC Cancer. 19(1). 941–941. 1 indexed citations

Kuroda, Shinji, Satoru Kikuchi, Naoto Hori, et al.. (2016). Training system for laparoscopy-assisted distal gastrectomy. Surgery Today. 47(7). 802–809. 13 indexed citations

Hasei, Joe, Tsuyoshi Sasaki, Hiroshi Tazawa, et al.. (2013). Dual Programmed Cell Death Pathways Induced by p53 Transactivation Overcome Resistance to Oncolytic Adenovirus in Human Osteosarcoma Cells. Molecular Cancer Therapeutics. 12(3). 314–325. 53 indexed citations

Yano, Shuya, Hiroshi Tazawa, Yuuri Hashimoto, et al.. (2013). A Genetically Engineered Oncolytic Adenovirus Decoys and Lethally Traps Quiescent Cancer Stem–like Cells in S/G2/M Phases. Clinical Cancer Research. 19(23). 6495–6505. 64 indexed citations

Tazawa, Hiroshi, Yuuri Hashimoto, Shuya Yano, et al.. (2012). Mechanism of resistance to trastuzumab and molecular sensitization via ADCC activation by exogenous expression of HER2-extracellular domain in human cancer cells. Cancer Immunology Immunotherapy. 61(11). 1905–1916. 22 indexed citations

Sasaki, Tsuyoshi, Hiroshi Tazawa, Joe Hasei, et al.. (2012). Preclinical evaluation of telomerase-specific oncolytic virotherapy for human bone and soft tissue sarcomas. Okayama Igakkai Zasshi (Journal of Okayama Medical Association). 124(2). 105–110. 1 indexed citations

Hashimoto, Yuuri, Hiroshi Tazawa, Fuminori Teraishi, et al.. (2012). The hTERT Promoter Enhances the Antitumor Activity of an Oncolytic Adenovirus under a Hypoxic Microenvironment. PLoS ONE. 7(6). e39292–e39292. 15 indexed citations

Sasaki, Tsuyoshi, Hiroshi Tazawa, Joe Hasei, et al.. (2011). Preclinical Evaluation of Telomerase-Specific Oncolytic Virotherapy for Human Bone and Soft Tissue Sarcomas. Clinical Cancer Research. 17(7). 1828–1838. 43 indexed citations

Kuroda, Shinji, Toshiya Fujiwara, Yasuhiro Shirakawa, et al.. (2010). Telomerase-Dependent Oncolytic Adenovirus Sensitizes Human Cancer Cells to Ionizing Radiation via Inhibition of DNA Repair Machinery. Cancer Research. 70(22). 9339–9348. 61 indexed citations

10.

Sakai, Ryo, Shunsuke Kagawa, Toru Kojima, et al.. (2010). Preclinical Evaluation of Differentially Targeting Dual Virotherapy for Human Solid Cancer. Molecular Cancer Therapeutics. 9(6). 1884–1893. 18 indexed citations

11.

Ikeda, Yoshihiro, Toru Kojima, Shinji Kuroda, et al.. (2009). A Novel Antiangiogenic Effect for Telomerase-Specific Virotherapy through Host Immune System. The Journal of Immunology. 182(3). 1763–1769. 16 indexed citations

12.

Watanabe, Yuichi, Toru Kojima, Shunsuke Kagawa, et al.. (2009). A novel translational approach for human malignant pleural mesothelioma: heparanase-assisted dual virotherapy. Oncogene. 29(8). 1145–1154. 29 indexed citations

13.

Kojima, Toru, Yuuri Hashimoto, Yuichi Watanabe, et al.. (2009). A simple biological imaging system for detecting viable human circulating tumor cells. Journal of Clinical Investigation. 119(10). 3172–3181. 84 indexed citations

14.

Hashimoto, Yuuri, Yuichi Watanabe, Futoshi Uno, et al.. (2008). Establishment of biological and pharmacokinetic assays of telomerase‐specific replication‐selective adenovirus. Cancer Science. 99(2). 385–390. 57 indexed citations

15.

Hioki, Masayoshi, Shunsuke Kagawa, Toshiya Fujiwara, et al.. (2008). Combination of oncolytic adenovirotherapy and Bax gene therapy in human cancer xenografted models. Potential merits and hurdles for combination therapy. International Journal of Cancer. 122(11). 2628–2633. 14 indexed citations

16.

Miyazaki, Masashi, et al.. (2007). Sevelamer Hydrochloride Exacerbates Metabolic Acidosis in Hemodialysis Patients, Depending on the Dosage. Therapeutic Apheresis and Dialysis. 11(2). 107–113. 21 indexed citations

17.

Takaoka, Munenori, Yoshio Naomoto, T. Ohkawa, et al.. (2003). Heparanase Expression Correlates with Invasion and Poor Prognosis in Gastric Cancers. Laboratory Investigation. 83(5). 613–622. 127 indexed citations

18.

Kataoka, Masafumi, Futoshi Uno, Tadashi Kondo, et al.. (2002). Activation of caspase-3 and cleavage of Rb are associated with p16-mediated apoptosis in human non-small cell lung cancer cells. Oncogene. 21(13). 2108–2113. 51 indexed citations

19.

Uno, Futoshi, Toshiyoshi Fujiwara, Yoshiko Takata, et al.. (2001). Antisense-mediated suppression of human heparanase gene expression inhibits pleural dissemination of human cancer cells.. PubMed. 61(21). 7855–60. 66 indexed citations

20.

Fukazawa, Takuya, Toshiyoshi Fujiwara, Futoshi Uno, et al.. (2001). Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells. Oncogene. 20(37). 5225–5231. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact